Rallybio RLYB
NASDAQ RLYB
$16.83 +0.23 (+1.39%)
As of: Aug 21, 2026 · 3:59 PM EDT

Rallybio (RLYB) Profit After Tax (2020 - 2026)

Rallybio (RLYB) posted Profit After Tax of -$8.3 million for Q1 2026, down 41.22% sequentially from -$5.9 million in Q4 2025, and up 12.32% YoY from -$7.4 million in Q1 2025.

Rallybio (RLYB) Profit After Tax (2020 - 2026) Analysis & Trends

Rallybio has reported Profit After Tax for 7 years, with the latest figure at -$8.3 million in Q1 2026.

  • Quarterly Profit After Tax rose 12.32% year-over-year to -$8.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.9 million (up 83.71% YoY) and the FY2025 annual result came in at -$9.0 million, up 84.42% from the prior year.
  • Profit After Tax fell to -$8.3 million in Q1 2026 per RLYB's latest filing, from -$5.9 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $16.0 million in Q3 2025 and troughed at -$20.3 million in Q4 2023.
  • A 5-year average of -$12.7 million and a median of -$15.8 million in 2022 frame the typical range for Profit After Tax.
  • The sharpest annual moves came in 2022 and 2025: Profit After Tax sank 80.79% in 2022, then surged 239.74% in 2025.
  • Over 5 years, Profit After Tax stood at -$15.8 million in 2022, then slipped by 28.59% to -$20.3 million in 2023, then soared by 44.78% to -$11.2 million in 2024, then jumped by 47.54% to -$5.9 million in 2025, then tumbled by 41.22% to -$8.3 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$8.3 million, -$5.9 million, and $16.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Rallybio 94.61 Mn 94.61 Mn - 43.67 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 43.67 Mn
Mar 31, 2026 -8.30 Mn
Dec 31, 2025 -5.87 Mn
Sep 30, 2025 16.02 Mn
Jun 30, 2025 -9.73 Mn
Mar 31, 2025 -9.46 Mn
Dec 31, 2024 -11.20 Mn
Sep 30, 2024 -11.47 Mn
Jun 30, 2024 -16.24 Mn
Mar 31, 2024 -19.03 Mn
Dec 31, 2023 -20.28 Mn
Sep 30, 2023 -18.37 Mn
Jun 30, 2023 -18.63 Mn
Mar 31, 2023 -17.17 Mn
Dec 31, 2022 -15.77 Mn
Sep 30, 2022 -18.43 Mn
Jun 30, 2022 -17.58 Mn
Mar 31, 2022 -14.62 Mn
Dec 31, 2021 -12.42 Mn
Sep 30, 2021 -10.20 Mn